These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34247514)

  • 1. The clinical value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) semi-quantitative parameters in monitoring neoadjuvant chemotherapy response of osteosarcoma.
    Zeng YN; Zhang BT; Song T; Peng JF; Wang JT; Yuan Q; Tan MY
    Acta Radiol; 2022 Aug; 63(8):1077-1085. PubMed ID: 34247514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
    J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging for neoadjuvant chemotherapy response evaluation in patients with osteosarcoma.
    Yin P; Xu J; Sun X; Liu T; Chen L; Hong N
    Eur J Radiol; 2023 May; 162():110790. PubMed ID: 36963332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy.
    Zhang L; Ge Y; Gao Q; Zhao F; Cheng T; Li H; Xia Y
    Front Oncol; 2021; 11():758921. PubMed ID: 34868973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
    Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
    Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
    Guo W; Zhang Y; Luo D; Yuan H
    Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
    Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
    Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
    Xu HD; Zhang YQ
    Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
    Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
    Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
    Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
    Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
    Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
    Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of semi-quantitative and quantitative dynamic contrast-enhanced MRI in evaluating the response to concurrent chemoradiotherapy in patients with non-small cell lung cancer].
    Xiuli T; Han O; Ning W; Li L; Feng Y; Ying S; Peihua W; Lü L
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):272-7. PubMed ID: 26462891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
    Jun W; Cong W; Xianxin X; Daqing J
    Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
    Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
    J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer.
    Liang X; Chen X; Yang Z; Liao Y; Wang M; Li Y; Fan W; Dai Z; Zhang Y
    BMC Cancer; 2022 Dec; 22(1):1250. PubMed ID: 36460972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
    Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
    Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of quantitative dynamic contrast-enhanced magnetic resonance imaging for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer].
    Zhu YJ; Li Y; Jiang J; Zhang W; Xue LY; Zhou AP; Jiang LM
    Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):765-770. PubMed ID: 31648499
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy response.
    Hao Y; An R; Xue Y; Li F; Wang H; Zheng J; Fan L; Liu J; Fan H; Yin H
    Eur Radiol; 2021 May; 31(5):3518-3529. PubMed ID: 33146792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.